{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:12:27Z","timestamp":1778350347945,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ejmech.2014.02.011","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T12:17:07Z","timestamp":1392034627000},"page":"98-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["In search of Flavivirus inhibitors part 2: Tritylated, diphenylmethylated and other alkylated nucleoside analogues"],"prefix":"10.1016","volume":"76","author":[{"given":"Milind","family":"Saudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Zmurko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jef","family":"Rozenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Van Aerschot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.02.011_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annual Review of Microbiology"},{"key":"10.1016\/j.ejmech.2014.02.011_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0065-3527(08)60316-4","article-title":"Flavivirus replication strategy","volume":"33","author":"Westaway","year":"1987","journal-title":"Advances in Virus Research"},{"key":"10.1016\/j.ejmech.2014.02.011_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.02.011_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.ejmech.2014.02.011_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1473-3099(01)00171-2","article-title":"Dengue: an update","volume":"2","author":"Guzm\u00e1n","year":"2002","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.ejmech.2014.02.011_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2014.02.011_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CMR.3.4.376","article-title":"The dengue viruses","volume":"3","author":"Henchal","year":"1990","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.ejmech.2014.02.011_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/511869","article-title":"Yellow fever: epidemiology and prevention","volume":"44","author":"Barnett","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.ejmech.2014.02.011_bib9","first-page":"333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Journal Title Abbreviations for Science"},{"key":"10.1016\/j.ejmech.2014.02.011_bib10","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2014.02.011_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejmech.2013.04.034","article-title":"In search of Flavivirus inhibitors: evaluation of different tritylated nucleoside analogues","volume":"65","author":"Chatelain","year":"2013","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.011_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2013.01.011","article-title":"3',5' Di-O-trityluridine inhibits in\u00a0vitro Flavivirus replication","volume":"98","author":"De Burghgraeve","year":"2013","journal-title":"Antiviral Research"},{"key":"10.1016\/j.ejmech.2014.02.011_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1248\/cpb.53.313","article-title":"Synthesis of N3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice","volume":"53","author":"Shimizu","year":"2005","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"10.1016\/j.ejmech.2014.02.011_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/07328319708002521","article-title":"Convenient intermediates for the preparation of C-4 modified derivatives of pyrimidine nucleosides","volume":"16","author":"Miah","year":"1997","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.ejmech.2014.02.011_bib15","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.3390\/molecules18078524","article-title":"A\u00a0straightforward diphenylmethyl Protection method and deprotection of some pyrimidine nucleosides","volume":"18","author":"Saudi","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2014.02.011_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in medicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/j.ejmech.2014.02.011_bib17","series-title":"Frontmatter, in: Bioorganic and Medicinal Chemistry of Fluorine","first-page":"i","author":"B\u00e9gu\u00e9","year":"2007"},{"key":"10.1016\/j.ejmech.2014.02.011_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cbic.200301023","article-title":"Fluorine in medicinal chemistry","volume":"5","author":"B\u00f6hm","year":"2004","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2014.02.011_bib19","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals: looking beyond intuition","volume":"317","author":"M\u00c3\u00bcller","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2014.02.011_bib20","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1021\/jm800219f","article-title":"The Many roles for fluorine in medicinal chemistry","volume":"51","author":"Hagmann","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.011_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.ejmech.2014.02.011_bib22","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/jm0603623","article-title":"Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine","volume":"49","author":"Pierra","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.011_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Research"},{"key":"10.1016\/j.ejmech.2014.02.011_bib24","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of Flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.ejmech.2014.02.011_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/nar\/3.4.989","article-title":"Reaction of diazoalkanes with 1-substituted 2, 4-dioxopyrimidines. Formation of O2, N-3 and O4-alkyl products","volume":"3","author":"Ku\u015bmierek","year":"1976","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.ejmech.2014.02.011_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/bj1350203","article-title":"The alkylation of 2'-deoxyguanosine and of thymidine with diazoalkanes. Some observations on O-alkylation","volume":"135","author":"Farmer","year":"1973","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.ejmech.2014.02.011_bib27","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1021\/ja01556a016","article-title":"Studies on polynucleotides. I. A new and general method for the chemical synthesis of the C5\u2033-C3\u2033 internucleotidic linkage. Syntheses of deoxyribo-dinucleotides1","volume":"80","author":"Gilham","year":"1958","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.ejmech.2014.02.011_bib28","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/ejoc.200901428","article-title":"Chemoenzymatic synthesis of 3\u2032-O-acetal-protected 2\u2032-deoxynucleosides as building blocks for nucleic acid chemistry","volume":"2010","author":"Rodr\u00edguez-P\u00e9rez","year":"2010","journal-title":"European Journal of Organic Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.011_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-1980-28965","article-title":"Two-stage synthesis of 3\u2032-O-tritylthymidine via hydrolysis of 3\u2032, 5\u2032-di-O-tritylthymidine; comparison with alternative methods","volume":"1980","author":"Davies","year":"1980","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2014.02.011_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/jo01322a025","article-title":"4'-Substituted nucleosides. 5. Hydroxymethylation of nucleoside 5'-aldehydes","volume":"44","author":"Jones","year":"1979","journal-title":"The Journal of Organic Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.011_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0008-6215(00)85610-4","article-title":"Stereochemical control as a function of protecting-group participation in 2-deoxy-D-erythro-pentofuranosyl nucleosides","volume":"90","author":"Wierenga","year":"1981","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.ejmech.2014.02.011_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/07328318708056266","article-title":"The 9-Fluorenylmethyloxycarbonyl (Fmoc) group as a 5\u2032-O base labile protecting group in solid supported oligonucleotide synthesis","volume":"6","author":"Ma","year":"1987","journal-title":"Nucleosides, Nucleotides and Nucleic Acids"},{"key":"10.1016\/j.ejmech.2014.02.011_bib33","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1039\/JR9550002632","article-title":"Nucleotides part XXXII. Synthesis of a dithymidine dinucleotide containing a 3(prime or minute): 5[prime or minute]-internucleotidic linkage","author":"Michelson","year":"1955","journal-title":"Journal of the Chemical Society"},{"key":"10.1016\/j.ejmech.2014.02.011_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0040-4039(01)95650-3","article-title":"Use of the tert-butyldimethylsilyl group for protecting the hydroxyl functions of nucleosides","volume":"14","author":"Ogilvie","year":"1973","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/j.ejmech.2014.02.011_bib35","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/S0040-4039(01)91764-2","article-title":"Selective protection of hydroxyl groups in deoxynucleosides using alkylsilyl reagents","volume":"15","author":"Ogilvie","year":"1974","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/j.ejmech.2014.02.011_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/jo01039a014","article-title":"Nucleosides. XVI. Further studies of Anhydronucleosides1","volume":"28","author":"Fox","year":"1963","journal-title":"The Journal of Organic Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.011_bib37","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/ja01480a026","article-title":"Nucleosides. XI. Synthesis of 1-\u03b2-D-arabinofuranosul-5-fluorouracil and related Nucleosides1","volume":"83","author":"Yung","year":"1961","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.ejmech.2014.02.011_bib38","unstructured":"L. Stuyver, K. Watanabe, Modified nucleosides for treatment of viral infections\u00a0and abnormal cellular proliferation, in, WO Patent 2,002,032,920, 2002."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:54:58Z","timestamp":1565171698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":38,"alternative-id":["S0223523414001317"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.02.011","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In search of Flavivirus inhibitors part 2: Tritylated, diphenylmethylated and other alkylated nucleoside analogues","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}